Politicizing Antibody Tests

Sadly, politicians and a liberal news media are trying to rewrite the science on antibodies. When the whole world is looking for hope for a way out of this corona virus pandemic, these people are questioning the protection that antibodies provide against reinfection with the virus.

Manish Butte, an associate professor and chief of pediatric allergy, immunology and rheumatology at UCLA, and Andrew Bogan, a molecular biologist, write in The Wall Street Journal to help clarify the science behind antibodies. They discuss two type of immune responses to viral infection: innate response and adaptive response.

Innate response occurs within minutes to hours and triggers alarms that result in effects across the body such as fever. Tissues and cells produce “interferons”, molecules that incapacitate many viruses and recruit white blood cells to destroy them. For mild infections, innate responses are sufficient to defeat the virus.

But some viral infections require a second wave of response, adaptive response, which arrives four or five days after infection. Molecular bits of the offending pathogen, known as antigens, are brought to the lymph nodes, where white blood cells called T and B lymphocytes attack the infected tissues, such as the lung for Covid-19. They release cytotoxins to kill infected cells. The over-aggressive immune response causes much of the devastation seen in severe cases of the disease.

As a result of this response, B cells produce antibodies that over several weeks adapt to the pathogen. After the war is over, a few T and B cells linger in the lymph nodes and in the mucosa of the airways, forming an “immunological memory” that is programmed to fight faster and stronger the next time that pathogen appears. This cell memory provides “protective immunity”, which Thucydides first hypothesized in 430 B.C.

For decades, antibody tests have been used as proof of immune response, arising either from infection or vaccination. The presence of antibodies can be detected from a blood sample using a serologic assay. Several tests have published sensitivity and specificity values as high as 99.6% to 100%. These tests are consistent with other antibody tests, such as those for mononucleosis and hepatitis infections, that are in routine use without much concern about their accuracy.

Which brings us to the question, “Why are people doubting the accuracy of antibody tests and claiming they don’t protect people from reinfection with the Covid-19 virus?

Butte and Bogan respond:

“Given the reliability and performance of these tests, it appears to be politics, not science, that is behind the claim that the presence of specific antibodies in those who’ve recovered from Covid-19 doesn’t indicate protective immunity. This is baffling. If it’s true, how does anyone recover from a severe infection?

If these antibodies aren’t protective, then global efforts to develop a vaccine are pointless. Vaccines try to arm T and B cells so they fight quickly when exposed to the virus. If antibodies detected in a person who has recovered don’t confer immunity, then neither would antibodies developed in response to a vaccine. The far more likely scenario, which is true of other corona viruses, is that antibodies do offer protection for a significant duration, so that a successful vaccine could be developed.”

The greatest disappointment of this virus pandemic may be the politicization of the response by those who would prefer a prolonged fear of the virus and shutdown of the economy for months to come – or at least until after the November presidential election.

Talcum Powder Won the Science Battle – But Lost the War

Johnson & Johnson has waved the white flag. Recently they announced they would discontinue sales of talcum-based baby powder in the U.S. and Canada, which they have sold since 1894.

As shocking as this sounds, it should be no surprise to anyone who watches television lately. The airwaves have been filled with trial attorneys soliciting anyone who has used baby powder in their lifetime and suffered from ovarian cancer. These ads would have you believe that talcum powder has been proven as a cause of cancer. Except, it hasn’t.

I wrote about this travesty of the legal system in 2017 in a post called The Talcum Powder Cancer Scare. At that time a jury found for a plaintiff who had terminal ovarian cancer and awarded her $417 million for J & J’s failure to warn her about the risk of using their product. She had been using baby powder for over 40 years.

But the scientific evidence did not support the jury’s findings. The American Cancer Society statement was as follows:

“Many studies in women have looked at the possible link between talcum powder and cancer of the ovary. Findings have been mixed, with some studies reporting a slightly increased risk and some reporting no increase. Many case-control studies have found a small increase in risk. But these types of studies can be biased because they often rely on a person’s memory of talc use many years earlier. Two prospective cohort studies, which would not have the same type of potential bias, have not found an increased risk.”

 

Johnson & Johnson was awarded a new trial at that time by California Superior Court Judge Maren Nelson to appeal the verdict. Judge Nelson stated, “The documents and testimony, granting all evidence in favor of the plaintiff do not support liability . . . much less support a finding of clear and convincing evidence that a punitive damage was appropriate.”

At that time, it seemed this attempt by the tort lawyers to turn talcum powder into the next asbestos racket would be thwarted. But alas, such was not the case. The legal system enthusiasm for suiting J & J has grown, while the scientific evidence to support their claims remains lacking.

A January, 2020 study published in the Journal of the American Medical Association (JAMA) followed more than 250,000 American women for 11 years and found no significant ovarian-cancer risk associated with talcum-powder use.The Centers for Disease Control and Prevention (CDC) does not list talcum powder as an ovarian cancer risk. The Food and Drug Administration (FDA) has consistently found insufficient evidence to mandate an ovarian-cancer warning label on talcum powder.

James R. Copland, writing in The Wall Street Journal, says this disconnect between science and the tort system doesn’t exist in other developed countries. He says regulators would apply the best science and essentially end the matter. But not in the U.S., where claims that a product causes an injury are typically matters of state law. An FDA determination that a product is safe doesn’t usually preclude litigation alleging otherwise.

Juries have often found in favor of Johnson & Johnson. They won 8 jury verdicts in 2019. But five other juries found for the plaintiffs in the same year and awarded heavy damages. Between 2016 and 2018, five different juries in St. Louis returned verdicts totaling almost $5 billion. Two-thirds of the early series of talcum cases were filed in St. Louis, even though the headquarters of J & J is over a thousand miles away in New Jersey. It seems that St. Louis has earned a reputation for plaintiff-friendly and generous juries.

The Covid-19 pandemic has made for empty shelves where hand-sanitizer and sanitary wipes used to sit. Looks like talcum powder is about to be the next item scarce to find.

 

To Mask or Not to Mask?

Do you need to wear a mask to protect yourself from the Covid-19 virus? That is the question on the mind of nearly everyone in the world today.

Advice from government and healthcare officials has been contradictory on this subject.
Dr. Mark Siegel, professor of medicine at NYU Langone Medical Center, addressed this subject recently in The Wall Street Journal. Siegel admits the message from medical authorities has been confusing. Both the U.S. Surgeon General and the Centers for Disease Control and Prevention exhorted Americans not to wear masks in January and February and then reversed their advice in April. What to believe?

Mask wearing has now become mandatory in many environments, including workplaces, airlines, and other public places. People wear masks when they are outside walking and others wear them when driving alone in their cars. When does it really make sense to wear a mask and when is it unnecessary?

The Purpose of the Mask

What exactly is the purpose of the mask? As a surgeon, I have worn a mask for every surgical procedure I have ever performed. That’s over forty years of wearing masks routinely. I wear the mask to prevent spread of my germs into the surgical environment, lest the patient be contaminated by me. I do not wear the mask to prevent contracting disease from the patient except in extreme situations when the patient may be infected with a contagious disease. In such cases I will also wear a face shield.

The wearing of masks today is to prevent contracting or spreading the Covid-19 virus. To prevent contracting the virus, you must understand how the virus is spread. This virus is spread by droplets and not by aerosolized virus particles. That means your risk for contracting the virus is directly related to contact with virus droplets, not inhaling virus particles. The typical spread occurs when virus droplets contaminate a surface, or skin, and your hands touch that surface or skin. Then your hands touch your face and you contaminate yourself. Therefore, it is crucial that you be aware of what surfaces your hands touch and then you avoid touching your face. The main value of wearing the mask is to prevent you from touching your face. It will also reduce the chance of spreading infection to others if you happen to be an asymptomatic carrier of the virus.

Masks are mostly useful for preventing infected individuals from spreading their virus particles to others through coughing, sneezing, or spitting. Surgical masks and even cloth masks can be effective. A study published in Nature Medicine in April examined 246 people with acute upper respiratory illness and found that wearing a surgical mask did decrease spread of genetic material from respiratory viruses, including coronaviruses. However, another study published in the Annals of Internal Medicine in April revealed that the force of sick patients’ coughs propelled droplets through both surgical masks and cloth. This highlights the importance of isolating those infected individuals who are coughing or sneezing.

What about those N-95 masks we have heard so much about?

The N-95 masks are actually more like respirators which are made to form a tight seal around the face and to maximize filtration of the air. When properly fitted, these masks prevent inhalation of non-filtered air. They are only needed by healthcare workers in close contact with infected patients during procedures such as intubation, suctioning of airways and giving respiratory therapy.

In summary, wear a mask to keep from touching your face when potentially in contact with contaminated surfaces in public places. Wear a mask when you’re sick to prevent the spread of your germs or virus particles to others. Wear a mask when you’re in public places that require them. Don’t wear a mask in your home unless you’re sick. Don’t wear a mask when you’re outdoors and not in close contact with others. Be aware of everything you touch in public places and keep hand sanitizer readily available. You can do this!